Boston Biopharma
Boston Biopharma is a pharmaceutical company headquartered in the United States, specializing in specialty medications for emerging markets with additional facilities in Malta and Lithuania.
Services
Boston Biopharma specializes in providing specialty medications worldwide, particularly in emerging countries. They develop and manufacture pharmaceutical products, ensuring high product quality and operational flexibility to meet global market demands. The company is involved in all stages from research and development to the final distribution of their medications.
Locations
Boston Biopharma is headquartered in the United States. They also operate an office in Malta and maintain a manufacturing and R&D site in Lithuania. This strategic presence enables them to efficiently manage operations and comply with regulatory standards in various global markets.
Products
Boston Biopharma offers a range of pharmaceutical products, including cancer medications, inhalation anesthesia, and cystic fibrosis treatments. Their cancer medications include luteinizing hormone-releasing hormone (LHRH) agonists and alkylating agents, which are approved in the EU. They also produce US-made inhalation anesthetic agents for general anesthesia during surgeries. For cystic fibrosis patients, they provide CFTR potentiators, used alone or in combination for specific genetic mutations.
Global Partnerships
Boston Biopharma partners with institutions in many countries to bring their pharmaceutical expertise to local markets. This collaboration helps in leveraging local knowledge and resources to ensure the effective distribution and administration of their products.